Clinical pharmacology of intravitreal anti-VEGF drugs.

about

Clinical pharmacology of intravitreal anti-VEGF drugs.

Item

http://www.wikidata.org/entity/Q48109878

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Clinical pharmacology of intravitreal anti-VEGF drugs.

@en

Clinical pharmacology of intravitreal anti-VEGF drugs.

@nl

type

Item

label

Clinical pharmacology of intravitreal anti-VEGF drugs.

@en

Clinical pharmacology of intravitreal anti-VEGF drugs.

@nl

prefLabel

Clinical pharmacology of intravitreal anti-VEGF drugs.

@en

Clinical pharmacology of intravitreal anti-VEGF drugs.

@nl

P1476

Clinical pharmacology of intravitreal anti-VEGF drugs

@en

P2093

Chiara Posarelli

http://www.w3.org/2001/XMLSchema#string

Eleonora Rofi

http://www.w3.org/2001/XMLSchema#string

P2860

Anti-vascular endothelial growth factor for neovascular glaucoma

Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1

VEGF-Trap: a VEGF blocker with potent antitumor effects.

Ranibizumab and bevacizumab for treatment of neovascular age-related macular degeneration: two-year results

Defining response to anti-VEGF therapies in neovascular AMD

Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial

Targeted deletion of Vegfa in adult mice induces vision loss

Ranibizumab for neovascular age-related macular degeneration

Comparison of Aflibercept, Bevacizumab, and Ranibizumab for Treatment of Diabetic Macular Edema: Extrapolation of Data to Clinical Practice.

Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in diabetes (READ-2) study.

P2888

s41433-018-0021-7

P304

1010-1020

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41433-018-0021-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-02-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29398697

http://www.w3.org/2001/XMLSchema#string

P932

5997665

http://www.w3.org/2001/XMLSchema#string